-
20-03-2021, 12:15 PM
#19041
Member
Originally Posted by Balance
You are wrong of course.
$5.00? That was only the first stop towards $10.00 at least imo at that time.
That is until the failure to clarify & substantiate the 'several tens of thousands of tests' comment by the then Chairman Swann & the selling of shares by DD (twice) & the chairman after the very bullish comments, remember?
And the Huljichs & Masfens took the same opportunity to sell heaps of their shares as well on the back of the spike in the sp following the Chairman's extremely bullish comments?
One of the most disgraceful episodes in NZ's corporate history imo.
Is this something that happened in 2015?
-
20-03-2021, 01:22 PM
#19042
Originally Posted by calledone
Is this something that happened in 2015?
Dec 2013 when Swann made the comments & share sales by insiders took place in early 2014.
https://www.odt.co.nz/business/pacific-edge-business
“ ..... several tens of thousands of tests” in 2014 & US$100m revenues in 5 years.
Fast forward to 2020:
16,861 tests done in FY2020
Revenues NZ$4.4m
-
20-03-2021, 02:39 PM
#19043
Member
Originally Posted by Balance
Dec 2013 when Swann made the comments & share sales by insiders took place in early 2014.
https://www.odt.co.nz/business/pacific-edge-business
“ ..... several tens of thousands of tests” in 2014 & US$100m revenues in 5 years.
Fast forward to 2020:
16,861 tests done in FY2020
Revenues NZ$4.4m
Looks like they were off by about 10 years haha! 100m might be possible by 2025 if new markets open up and US market is tracking according to plan without any major headwinds.
I noticed their cxbladder tests can now be bought online by anyone locally. Thought that was an interesting development. https://order.cxbladder.com/index.ph...&product_id=50
Last edited by calledone; 20-03-2021 at 02:42 PM.
-
20-03-2021, 03:29 PM
#19044
Originally Posted by calledone
Looks like they were off by about 10 years haha! 100m might be possible by 2025 if new markets open up and US market is tracking according to plan without any major headwinds.
I noticed their cxbladder tests can now be bought online by anyone locally. Thought that was an interesting development. https://order.cxbladder.com/index.ph...&product_id=50
That's all in the past of course - what's important is how PEB is going to fare going forward with 2020 being the year of the reset imo.
2 things which will drive the sp in the next results = reimbursement of the US$40m tests done but not paid & how many tests done since the LCD was obtained.
Comfortable to hold until then.
-
21-03-2021, 11:29 AM
#19045
Junior Member
-
21-03-2021, 12:02 PM
#19046
Member
Originally Posted by Balance
That's all in the past of course - what's important is how PEB is going to fare going forward with 2020 being the year of the reset imo.
2 things which will drive the sp in the next results = reimbursement of the US$40m tests done but not paid & how many tests done since the LCD was obtained.
Comfortable to hold until then.
Sorry Balance, could you remind me where this $40m figure is coming from for the potential CMS reimbursement? There are 22,000+ tests which they are negotiating reimbursement for, and the agreed price per test from 1 July 2020 is US$760 per test. I can't quite tie up the $40m figure that seems to be bouncing around.
-
21-03-2021, 03:37 PM
#19047
Originally Posted by jridler
Sorry Balance, could you remind me where this $40m figure is coming from for the potential CMS reimbursement? There are 22,000+ tests which they are negotiating reimbursement for, and the agreed price per test from 1 July 2020 is US$760 per test. I can't quite tie up the $40m figure that seems to be bouncing around.
https://businessdesk.co.nz/article/c...-administrator
Pacific Edge is chasing 22,000 outstanding invoices dating back to 2015 as it seeks up to US$40 million in backpay from US medical aid administrator Novitas.
-
21-03-2021, 03:38 PM
#19048
Originally Posted by jridler
Sorry Balance, could you remind me where this $40m figure is coming from for the potential CMS reimbursement? There are 22,000+ tests which they are negotiating reimbursement for, and the agreed price per test from 1 July 2020 is US$760 per test. I can't quite tie up the $40m figure that seems to be bouncing around.
https://businessdesk.co.nz/article/c...-administrator
Pacific Edge is chasing 22,000 outstanding invoices dating back to 2015 as it seeks up to US$40 million in backpay from US medical aid administrator Novitas.
-
21-03-2021, 06:32 PM
#19049
"Hello is that Novias? its PEB here could you pay us $40miilion?
Novitas: "do we have to?"
PEB: "no"
Novitas: "Goodbye"
-
21-03-2021, 07:33 PM
#19050
So the conclusion we can come to with all that is that any competitor looking to enter the field would be obliged to stump up some 20,000 odd tests free of charge to get recognised.Would be a big ask, that one.Might look at the NZ US exchange rate as an indicator as to the amounts but it does seem that 40mill is a bit high.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks